The company key assets the Lochend Cardium and the core Oklahoma Hunton field is yet to be sold or dealt with, everything you have seen so far is trimming around the edges. Equal continue to be undervalued on all key metrics (per flowing, per BOE P1/P2 and EV to DACF), the only thing holding the stock is the uncertainty about when the review will be concluded, or how it will be concluded, the most
...more